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doi:10.1016/j.ijid.2007.01.007Figure 1 Apical cavitation of the left lung.Invasive Aspergillus fumigatus associated with
liver and bone involvement in a patient with
AIDS
A 39-year-old male who had emigrated from Malawi to the UK
presented to his general practitioner with an eight-week
history of an intermittent non-productive cough. He had
no hemoptysis or constitutional symptoms and was a non-
smoker. He reported having been hospitalized for twomonths
in Malawi for pulmonary Mycobacterium tuberculosis infec-
tion (PTB) eighteen years previously. He was referred to the
hospital outpatient clinic for further evaluation.
Examination findings included decreased air entry at the
left apex of the lung. A chest radiograph (CXR) showed left
apical opacification and cavitation with associated volume
loss (Figure 1). Sputum analysis for bacteria and acid-fast
bacilli (AFB) were negative on special staining and culture.
These findings were interpreted as representing previously
treated PTB infection. The patient consented to HIV testing
and was found to be HIV-1 antibody positive with a CD4 count
of 21  106 cells/l (2%) and HIV viral load of 233 000 copies/
ml. Co-infection with hepatitis B was confirmed by serology:
HBsAg positive and HBeAg positive. Co-trimoxazole was
started for Pneumocystis prophylaxis.
Four weeks later he re-presented to hospital with a one-
week history of severe frontal headache and general malaise,
but no fevers, photophobia or nuchal rigidity. Clinical exam-
ination was unremarkable except for the previously noted
findings in the left lung field. A serum cryptococcal latex
agglutination test (CrAg) was positive at a titer of 1:20.
Lumbar puncture evaluation revealed an opening pressure
of 18 cmH2O and microscopy confirmed the presence of
Cryptococcus on India ink staining, a white cell count
(WCC) of 2550 cells (95% mononuclear cells, 5% polymorphs)
and fewer than five red blood cells. Cerebrospinal fluid (CSF)
protein was 1266 mg/l (normal range 250—450 mg/l). The
CSF glucose:plasma glucose ratio was 1:2. CSF CrAg was
positive at a titer of 1:40. The patient was commenced on
intravenous amphotericin B and flucytosine. Cryptococcus
neoformans was cultured from the CSF. Abnormal results
were also obtained for: hemoglobin (Hb) 7.9 g/dl (normal
range 13.0—16.5 g/dl); mean cell volume (MCV) 75.5 fl (nor-
mal range 79—96.0 fl); WCC 3.95  109 cells/l (normal range
4.00—11.0  109 cells/l); and lymphocytes 0.85  109 cells/l
(normal range 1.30—4.00  109 cells/l). Neutrophils were
2.60  109 cells/l (normal range 2.50—7.50  109 cells/l).
During treatment for cryptococcal meningitis, the patient
complained of a productive cough of yellow sputum and
pleuritic chest pain. A repeat CXR revealed cavitation in
the apex of the left lung, unchanged from the investigationsof four weeks previously. A fibreoptic bronchoscopy was
normal and staining and cultures of bronchoalveolar lavage
(BAL) fluid were negative for bacteria, Pneumocystis jirovecii
(Pneumocystis pneumonia, PCP) and mycobacteria. Six
further sputum samples were negative for bacteria and
mycobacteria on stain and culture. A course of oral co-
amoxiclav was prescribed for a presumed bacterial chest
infection, which resulted in an improvement in his respira-
tory symptoms. Prior to discharge the patient was converted
to oral fluconazole 400 mg daily. Two weeks following dis-
charge he was clinically well and commenced on anti-retro-
viral therapy consisting of zidovudine, lamivudine and
efavirenz.
Five months after diagnosis of cryptococcal meningitis the
patient presented with a productive cough and pleuritic
chest pain localized to the left apex. He denied any hemop-
tysis. On examination he was afebrile and decreased air entry
was again noted in the left upper lobe. Investigations showed
a WCC 3.72  109 cells/l, Hb 9.3 g/dl, MCV 87.9 fl, platelets
573  109/l (normal range 150—450  109/l), neutrophils
1.98  109 cells/l, and lymphocytes 0.65  109 cells/l. C-
Reactive protein (CRP) was elevated at 192.1 mg/l (normal
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Figure 3 Abdominal computed tomography scan identifying
the presence of small focal low-density lesions within the liver
and spleen.range<5 mg/l) and the erythrocyte sedimentation rate (ESR)
was 82 mm/h (normal range 1—10 mm/h). After 18 weeks on
antiretroviral therapy the CD4 count was 11  106 cells/l and
the viral load had fallen to <50 copies/ml. Intravenous co-
amoxiclav was commenced empirically to treat suspected
community-acquired pneumonia. Routine and mycobacterial
blood cultures were negative.
A CXR showed progressive changes within the left hemi-
thorax (Figure 2). A thoracic computed tomography (CT) scan
showed dense consolidation within the left upper zone asso-
ciated with marked cavitation and intracavitary material
together with marked volume loss within the left hemithorax
and a left-sided pleural effusion. Abdominal CT revealed
numerous small focal low-density lesions in the liver, spleen
and bone (Figure 3). Whilst the diagnosis of an aspergilloma
was thought to be reasonable based on the appearances of
the chest CT, the additional radiographic findings in the bone
and liver strongly suggested disseminated tuberculosis (TB).
A whole body bone scan was performed and showed normal
uptake of tracer in all parts of the skeleton.
A repeat bronchoscopy was performed: bacteria, PCP and
AFB were not identified on staining of the BAL but septated
hyphae were stained and the appearance was consistent with
Aspergillus. The patient was switched from fluconazole to
voriconazole to treat presumptive invasive aspergillosis (IA).
Culture of the BAL later grew Aspergillus fumigatus. The
aspirate from pleural fluid contained a few reactive mesothe-
lial cells, macrophages, lymphocytes, occasional neutrophils
and red blood cells. Culture of this fluid was negative for
bacteria, fungi and mycobacteria.
A bone marrow aspirate and trephine were performed
prior to commencement of voriconazole. Histology showed a
reactive marrow consistent with HIV myelopathy, patchyFigure 2 Progression of left lung apical cavitation with con-
solidation and associated volume loss of hemithorax.myelofibrosis and reactive plasma cell infiltration and no
granulomas. Multiple echogenic lesions with hyper-echoic
centers were noted throughout the liver and spleen on
ultrasound examination. Liver biopsy revealed no granulo-
mata or fungal forms. Histology was consistent with a lobular
hepatitis of minimal activity and evidence of hepatitis B
infection.
In view of the radiographic deterioration and despite the
absence of granulomas on bonemarrow and liver specimens it
was felt that the radiographic pictures remained consistent
with disseminated mycobacterial infection. The patient was
commenced on quadruple anti-tuberculous therapy consist-
ing of rifampicin1, isoniazid, ethambutol and pyrazinamide.
Clarithromycin was co-administered to cover suspected
Mycobacterium avium intracellulare infection.
Microbiological culture of the bone marrow and liver
samples subsequently grew A. fumigatus. Treatment of pre-
sumed disseminated mycobacterial and aspergillus disease
was continued for four weeks on an inpatient basis. During
this time there was normalization of the WCC and neutrophil
count. The CRP decreased to 36.3 mg/l and ESR to 22 mm/h.
Improvement of cough and pleuritic chest pain was
achieved at discharge. A further CXR showed that parench-
ymal changes seenwithin the left lung had improved together
with resolution of the pleural effusion. Medication on dis-
charge included co-trimoxazole, rifabutin, ethambutol, pyr-
azinamide, isoniazid, pyridoxine, tenofovir, emtricitabine,
efavirenz and voriconazole.
Aspergillus fumigatus was confirmed on culture of BAL,
bone marrow sample and liver biopsy. Aspergillus fumigatus
was not isolated from blood culture. The A. fumigatus radio-
allergosorbent test (RAST) test was negative but Aspergillus
antigen (monoclonal antibody to galactomannan) enzyme-
linked immunosorbent assay was positive. TB therapy was
discontinued when final TB cultures revealed no growth.
Voriconazole treatment for disseminated aspergillosis was
continued on an outpatient basis with gradual resolution of
the patient’s respiratory and systemic symptoms.
Aspergillus is a spore-forming (conidia) fungus with more
than 185 species in the genus and 20 types reported to cause
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inhalation of spores. Aspergillus fumigatus is the most com-
monly isolated species.
Aspergillus spp are infrequently implicated in disease in
healthy hosts. Protection from infection depends on granu-
locyte function as phagocytes kill the conidia. Prolonged
neutropenia is the predominant risk factor for developing
IA.1—3 Thus immunosuppression, corticosteroid use and par-
enteral antibiotic use are cited as major risk factors for the
development of invasive disease.
Aspergillosis is not included in the list of AIDS-defining
conditions produced by the Centers for Disease Control,4 and
IA is uncommon in HIV-infected individuals with an incidence
of less than 10%.5—7 The definition of disseminated IA requires
the demonstration of Aspergillus spp at two or more non-
contiguous sites.8 Our patient had a number of predisposing
risk factors for IA as a consequence of HIV infection. These
included neutropenia,1—3 CD4 lymphocytopenia,9 and a pre-
vious AIDS opportunistic infection.1,6,9
Pulmonary infection by Aspergillus is most common in
HIV-infected patients.1,2,6 In our patient we isolated A.
fumigatus from bronchoalveolar lavage. The specificity of
the isolation of Aspergillus spp is high for invasive disease in
immunocompromised hosts.10 Our patient also had pre-
existing pulmonary cavitation as a result of old PTB, this
being an independent risk factor for the development of
IA.11
Pulmonary aspergillosis is well documented in the litera-
ture12 and dissemination by hematogenous spread has been
observed. Hematogenous seeding of the axial skeleton, inter-
vertebral discs and vertebral bones frequently complicates
IA.8 Osteomyelitis was confirmed by positive culture of a
posterior iliac crest bone marrow trephine. Abdominal CT
identified the presence of small low-density bone lesions.
Lesions were also visualized in the liver and Aspergillus
fumigatus was cultured from percutaneous liver biopsy.
Our patient had chronic hepatitis B infection, which has also
been proposed as a risk factor for IA.13 To our knowledge,
hepatic infection by Aspergillus spp in HIV co-infected
patients has not been documented previously in the litera-
ture.
This man had advanced immunosuppression secondary to
HIV infection with a CD4 count at diagnosis of 21  106 cells/
l. Lortholary et al. described a CD4 cell count of
<50  106 cells/l as being associated with aspergillosis.9
Prior cryptococcal meningitis may also be an independent
risk factor for the development of IA. Staib et al. noted that
in one group of patients with AIDS and cryptococcosis, 67%
had aspergilli isolated from their respiratory tracts.14 We
hypothesize that the accumulation of independent risk fac-
tors for IA in this individual accounted for the dissemination
of disease.
The diagnosis was initially suspected to be disseminated
mycobacterial infection given the clinical and radiographic
findings. The eventual diagnosis was proven disseminated IA
after isolation of A. fumigatus from three non-contiguous
sites: lung, liver and bone. Further features suggestive of
invasive disease include histopathological evidence from
BAL, positive radiological imaging and the presence of serum
Aspergillus antigen.
Amphotericin B is one of the preferred treatments for
invasive disease.15 This patient received exposure to ampho-tericin B for treatment of cryptococcal meningitis. We
hypothesize that the intravenous amphotericin B treatment
may have partially treated the pulmonary disease and so
interfered with BAL culture results. This resulted in a nega-
tive culture of the first BAL sample taken. Fluconazole has
little activity against Aspergillus hence disease progression
after conversion to this agent. After the identification of
Aspergillus in BAL the patient was treated with oral vorico-
nazole, which resulted in both clinical and radiological
improvements.16
Disseminated IA is uncommon in HIV-infected individuals.
Symptoms may mimic those of other infections. As illustrated
in this case, diseasemay occur at atypical sites. A high degree
of clinical suspicion for IA is necessary for HIV-infected
patients with numerous risk factors.
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Localized abscess in an organ is generally treated with
surgical drainage and, in some cases, systematic administra-
tion of appropriate antibiotics. Removal of an organ impaired
by infection is rarely performed except in critical cases. We
encountered a patient who required a penectomy for persis-
tent abscess of the corpus cavernosum due to secondary
infection with methicillin-resistant Staphylococcus aureus
(MRSA).
A 54-year-old man presented with a one-week history of
pain in the base of the penis unrelated to urination, with non-
systemic symptoms. The patient denied any recent sexually
transmitted disease, trauma, voiding symptoms, use of ure-
thral instruments, tuberculosis, and diabetes or other sys-
temic disease. He suffered from erectile dysfunction, which
had gone unattended. Physical examination revealed a pain-
ful nodule of the right and left corpus cavernosum close to
the crus of the penis and a normal prostate. Routine labora-
tory tests including urinalysis showed no abnormalities. T2-
weighted magnetic resonance imaging of the pelvis showed
localized bilateral abscess formation in the corpus caverno-sum (Figure 1). Exploration of the right base of the penile
shaft by lateral approach revealed a sterile abscess of the
cavernosum. Moreover, biopsy of the abscess wall showed
fibrous tissue but neither tubercular change nor cancerous
tissue. Although the patient’s symptoms disappeared tem-
porarily after removal of pus with a Penrose drain and
intravenous injection of a broad-spectrum antibiotic for 10
days, the wound ruptured spontaneously after three weeks
and discharged new pus, the culture of which yielded MRSA.
The drainage volume increased, and the pain in the penis
worsened daily. The patient was re-hospitalized after three
months due to gait disturbance and a fever of 38 8C, and was
given injections of vancomycin for seven days. Despite treat-
ment, his condition deteriorated, and a total penectomy and
perineal urethrostomy were performed. His condition
improved substantially, and he was discharged in good health
14 days later. The surgical specimen revealed various inflam-
matory infiltrates, granulomatous change, and cell debris in
the right and left corpus cavernosum with a few epithelioid
cells. Staining by the Ziehl—Neelsen method was negative;
however, culture of the surgical specimen forMycobacterium
was not performed.
Abscess of the corpus cavernosum is rare and can develop
after trauma,1 as a complication of cavernosography,2 as an
unusual presentation of gonorrhea,3 after intracorporeal
injections,4 or from undetermined causes,5,6 as in our case.
It can usually be managed by drainage and antibiotic ther-
apy;6,7 however, penectomy may be necessary in persistent
cases.
Conflict of interest: No conflict of interest to declare.
References
1. Niedrach WL, Lerner RM, Linke CA. Penile abscess involving the
corpus cavernosum: a case report. J Urol 1989;141:374—5.
2. Velcek D, Evans JA. Cavernosography. Radiology 1982;144:781—
5.
3. Rosen T. Unusual presentations of gonorrhea. J Am Acad Dermatol
1982;6:369—72.
4. Orvis BR, Lue TF. New therapy for impotence. Urol Clin North Am
1987;14:569—81.
5. Koksal T, Kadioglu A, Tefekli A, Usta M, Besisik A, Erol B. Sponta-
neous bacterial abscess of bilateral cavernosal bodies. BJU Int
1999;84:1107—8.
6. Pearle MS, Wendel EF. Necrotizing cavernositis secondary to
periodontal abscess. J Urol 1993;149:1137—8.
